WeVote
Log In

Bill

Bill

HB 2369

Central Criminal Records Exchange; removes requirement for annual reports.

2025 Regular Session Introduced by Tony Wilt

Allows pharmacists to order and administer FDA-approved vaccines to patients aged 7 and older under vaccination protocols, with certain vaccines and post-2023 approvals excluded.

Left in Public Safety
0
WeVote Research Nonpartisan
Bill Summary · HB 2369

Summary — HB 2369 (introduced February 3, 2025)

Title: Allowing pharmacists to administer certain vaccines to children and adults pursuant to a vaccination protocol
Status: Referred to Committee on Health and Human Services (introduced 02/03/2025)

Purpose / Intent

HB 2369 amends the Kansas Pharmacy Act to explicitly authorize pharmacists to order and administer FDA‑approved vaccines to patients when acting pursuant to a vaccination protocol. The overall intent is to expand pharmacists’ authority to provide routine immunizations to children and adults (subject to age and vaccine exclusions described below).

Key provisions

  • Authorizes pharmacists to order and administer any vaccine that is FDA‑approved or authorized, provided:
    • The vaccine is administered pursuant to a vaccination protocol; and
    • The recipient is at least seven years old or the minimum age specified in the vaccine authorization or CDC recommendation, whichever is older.
  • Prohibits pharmacists from administering vaccines that cannot appropriately be provided under a vaccination protocol. The bill lists vaccines that pharmacists may not administer, including:
    • Cholera, monkeypox, Japanese encephalitis, typhoid, rabies, yellow fever, tick‑borne encephalitis, anthrax, tuberculosis, dengue, Haemophilus influenzae type b (Hib), polio, rotavirus, and smallpox.
    • Also prohibits administration of any vaccine approved after January 1, 2023 that the Board of Pharmacy determines is not appropriate for protocol administration.
  • Authorizes the State Board of Pharmacy to adopt regulations adding other vaccines to the prohibited list (i.e., vaccines that cannot be administered by pharmacists under a vaccination protocol).
  • Repeals the existing version of K.S.A. 2024 Supp. 65‑1626a and replaces it with the amended text.
  • Effective date: upon publication in the statute book.

Who is affected

  • Pharmacists and pharmacies: expand scope of practice for administering vaccines to a broader set of FDA‑approved vaccines and to patients aged seven and older (as allowed by vaccine labeling/CDC guidance), but with listed exclusions and Board regulatory authority.
  • Patients and caregivers: increased potential access to routine immunizations through pharmacies for eligible ages and vaccines.
  • Board of Pharmacy: responsible for rulemaking to list additional vaccines that should be excluded and for oversight of any procedural matters arising from the change.
  • Other healthcare providers: potential impacts on vaccine delivery settings and workflows; collaborative practice provisions and physician roles referenced elsewhere in the pharmacy act remain in force.

Fiscal impact / implementation

  • Fiscal note (Kansas Division of the Budget, Feb. 14, 2025): The Board of Pharmacy expects increased staff time for duties under the bill (rulemaking, reviews, publication in the Kansas Register). Estimated costs would be absorbed within existing Board resources—no new appropriation requested in the fiscal note.

Procedural / timeline notes

  • Introduced: February 3, 2025; referred to the House Committee on Health and Human Services.
  • A subcommittee/public hearing was scheduled and took testimony on April 29, 2025 (record indicates the measure was left pending in subcommittee following that hearing).
  • The bill text states it becomes effective once published in the statute book if enacted.

Items to watch / uncertainties

  • The bill does not specify additional training, certification, standing order details, reimbursement changes, or liability protections for pharmacists beyond existing pharmacy act provisions.
  • The Board of Pharmacy’s forthcoming rulemaking (to list additional excluded vaccines) will determine operational scope and any further limitations.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.